Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9843907 | 0.78 | ALDH1A1 (0.40) | KDM4EGPR3MAPTLMNARAB9A | |
| SCHEMBL30198446 | 0.77 | CYP1A2 (0.60) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL1672650 | 0.77 | CYP1A2 (0.60) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL30527184 | 0.77 | CYP1A2 (0.60) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL4778401 | 0.75 | CYP1A2 (0.46) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL14099190 | 0.74 | CYP1A2 (0.53) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL13911016 | 0.73 | CYP1A2 (0.56) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL528392 | 0.71 | NPC1 (0.47) | CYP1A2KDM4EGPR3MAPTNPC1 | |
| SCHEMBL11060746 | 0.71 | TDP1 (0.40) | KDM4EMAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL1434260 | 0.71 | RAB9A (0.46) | CYP1A2KDM4EMAPTNPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339155-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | disclosed |
| CN-113166120-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | disclosed |
| CN-113227082-B | Compound and organic light emitting device using the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | disclosed |
| CN-113039184-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118339158-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-12 | — | — | CN | disclosed |
| CN-112789742-B | Organic light emitting device | 株式会社LG化学 | 2024-07-09 | — | — | CN | disclosed |
| CN-113166112-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-05 | — | — | CN | disclosed |
| CN-113498412-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-07-02 | — | — | CN | disclosed |
| CN-115135652-B | Novel compound and organic light emitting device including the same | 株式会社LG化学 | 2024-07-02 | — | — | CN | disclosed |
| CN-113727980-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-06-28 | — | — | CN | disclosed |
| EP-1326606-A2 | EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS | PFIZER PHARMACEUTICALS INC. (JP) | 2003-07-16 | — | — | EP | disclosed |
| EP-1326864-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2003-07-16 | — | — | EP | disclosed |
| US-20030130277-A1 | Pyrazoloquinolinone derivatives as protein kinase C inhibitors | KAWAMURA KIYOSHI (JP) | 2003-07-10 | — | — | US | disclosed |
| EP-1325921-A2 | Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators | Pfizer Inc. (US) | 2003-07-09 | — | — | EP | disclosed |
| EP-1310498-A2 | Pyrazoloquinolinone derivatives as protein kinase C inhibitors | PFIZER INC. (US) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002060896-A1 | ETHER DERIVATIVES USEFUL AS INHIBITORS OF PDE4 ISOZYMES | PFIZER PRODUCTS INC. (US) | 2002-08-08 | — | — | WO | disclosed |
| US-20020107273-A1 | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents | ASKAT INC. (JP) | 2002-08-08 | — | — | US | disclosed |
| US-20020077329-A1 | EP4 receptor inhibitors to treat rheumatoid arthritis | PFIZER PHARMACEUTICALS INC. (JP) | 2002-06-20 | — | — | US | disclosed |
| WO-2002032422-A2 | EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002032900-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130277-A1 | Pyrazoloquinolinone derivatives as protein kinase C inhibitors | PRKCB, PRKCA, PRKCG | CYP1A2 3063/4885KDM4E 1349/4885GPR3 907/4885 |
| US-20020107273-A1 | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents | PTGS1, PTGS2, OPRM1 | CYP1A2 139/4885KDM4E 3701/4885GPR3 393/4885 |
| US-20020077329-A1 | EP4 receptor inhibitors to treat rheumatoid arthritis | PTGER4, PTGER1, PTGER2 | CYP1A2 1271/4885KDM4E 1206/4885GPR3 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.